🇺🇸 FDA
Pipeline program

blood sampling (alpha-Galactosidase & LysoGb3)

FAPREV-HCM

Unknown other active

Quick answer

blood sampling (alpha-Galactosidase & LysoGb3) for Fabry Disease is a Unknown program (other) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Fabry Disease
Phase
Unknown
Modality
other
Status
active

Clinical trials